2018

★ Chiheal Biomed was founded to open the CRO operation mode.

2019

★ Chiheal Biomed established multiple layout, entered the innovative drug field and initiated MAH drugs R&D collaborations.

2020

★ Chiheal developed rapidly and began to build pharmaceutical factory.

2021

★ Chiheal Biomed optimized its internal structure, reduced costs, and improved efficiency. The CRO incomes doubled in scale. Innovative drug PCCs were continuously established.

2022

★ Chiheal Biomed entered a new era by introducing strategic cooperation and investment, driving deep development and efficient operations. It  further strengthened its R&D team, with a focus on advancing MAH cooperation projects and improving customer satisfaction. The pharmaceutical factory officially been put into operation.

2023

★ Chiheal Biomed completed its Series A financing, further strengthening its investment in R&D. The CRO, CMO, and CDMO models became increasingly mature. The first fast-follow innovative drug completed a transfer transaction.